Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Witt

Showing results (231-240 of 264) with videos related to

Pageof 27
Sort By:
AIDS (London, England)|February 25, 2025
Associations between HIV serostatus and coronary artery plaque volume progressionSeamus P Whelton, Sabina A Haberlen, Long Zhang, et al.
AIDS Patient Care and Stds|February 12, 2008
The costs of HIV antiretroviral therapy adherence programs and impact on health care utilizationStephanie L Sansom, Monique N Anthony, Wendy H Garland, et al.
The American Journal of Cardiology|February 3, 2016
Comparison of Insulin Resistance to Coronary Atherosclerosis in Human Immunodeficiency Virus Infected and Uninfected Men (from the Multicenter AIDS Cohort Study)Michael I Brener, Wendy S Post, Sabina A Haberlen, et al.
The Journal of Infectious Diseases|January 15, 2004
Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trialJoseph J Eron, Judith Feinberg, Harold A Kessler, et al.
The Journal of Infectious Diseases|November 2, 2014
Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infectionRebeccah A McKibben, Joseph B Margolick, Steven Grinspoon, et al.
The New England Journal of Medicine|August 8, 1996
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment GroupD V Havlir, M P Dubé, F R Sattler, et al.
Neuron|September 1, 1996
Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelinationL E Warner, M J Hilz, S H Appel, et al.
Journal of Cardiovascular Computed Tomography|March 8, 2016
Extra-coronary calcification (aortic valve calcification, mitral annular calcification, aortic valve ring calcification and thoracic aortic calcification) in HIV seropositive and seronegative men: Multicenter AIDS Cohort StudyPanteha Rezaeian, P Elliott Miller, Sabina A Haberlen, et al.
AIDS (London, England)|April 24, 2001
Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitorsC A Kemper, M D Witt, P H Keiser, et al.
AIDS (London, England)|October 20, 2023
Association of urine biomarkers of kidney health with subclinical cardiovascular disease among men with and without HIVMason Lai, Erin Madden, Michael G Shlipak, et al.
Pageof 27

Showing results (231-240 of 264) with videos related to

Sort By:
Pageof 27
AIDS (London, England)|February 25, 2025
Associations between HIV serostatus and coronary artery plaque volume progressionSeamus P Whelton, Sabina A Haberlen, Long Zhang, et al.
AIDS Patient Care and Stds|February 12, 2008
The costs of HIV antiretroviral therapy adherence programs and impact on health care utilizationStephanie L Sansom, Monique N Anthony, Wendy H Garland, et al.
The American Journal of Cardiology|February 3, 2016
Comparison of Insulin Resistance to Coronary Atherosclerosis in Human Immunodeficiency Virus Infected and Uninfected Men (from the Multicenter AIDS Cohort Study)Michael I Brener, Wendy S Post, Sabina A Haberlen, et al.
The Journal of Infectious Diseases|January 15, 2004
Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trialJoseph J Eron, Judith Feinberg, Harold A Kessler, et al.
The Journal of Infectious Diseases|November 2, 2014
Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infectionRebeccah A McKibben, Joseph B Margolick, Steven Grinspoon, et al.
The New England Journal of Medicine|August 8, 1996
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment GroupD V Havlir, M P Dubé, F R Sattler, et al.
Neuron|September 1, 1996
Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelinationL E Warner, M J Hilz, S H Appel, et al.
Journal of Cardiovascular Computed Tomography|March 8, 2016
Extra-coronary calcification (aortic valve calcification, mitral annular calcification, aortic valve ring calcification and thoracic aortic calcification) in HIV seropositive and seronegative men: Multicenter AIDS Cohort StudyPanteha Rezaeian, P Elliott Miller, Sabina A Haberlen, et al.
AIDS (London, England)|April 24, 2001
Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitorsC A Kemper, M D Witt, P H Keiser, et al.
AIDS (London, England)|October 20, 2023
Association of urine biomarkers of kidney health with subclinical cardiovascular disease among men with and without HIVMason Lai, Erin Madden, Michael G Shlipak, et al.
Pageof 27